NEW YORK (GenomeWeb News) – Women's health diagnostics company Inex Innovations Exchange announced today a partnership with BGI to create a next-generation sequencing facility in Singapore to offer molecular genetic tests.

The first test to be offered will be iGeneScreen, a non-invasive test developed by BGI to detect fetal chromosomal abnormalities. Using a 5 milliliter blood sample from expectant mothers at 12 weeks or later into their pregnancies, the test analyzes fetal DNA in maternal blood for trisomies 21, 18, and 13.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.